WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Abbott

AbbottAt Abbott, we're committed to helping you live your best possible life through the power of health. For more than 125 years, we've brought new products and technologies to the world - in nutrition, diagnostics, medical devices and branded generic pharmaceuticals - that create more possibilities for more people at all stages of life. Today, 73,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.

www.abbott.com

Abbott RSS Channel

Filters
List of articles in category Abbott
Title Published Date
Abbott Named One of the Top 10 Companies for Scientists 01 June 2009
Abbott's XIENCE V(R) Demonstrates Impressive Results in SPIRIT V Study 22 May 2009
New data to be presented on Abbott's market-leading XIENCE V(R) stent 20 May 2009
Abbott Reports 16 Percent Earnings Growth in First Quarter 17 April 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent 13 March 2009
Abbott Successfully Completes Tender Offer for Shares of Advanced Medical Optics 25 February 2009
Abbott Receives European Commission Clearance on Acquisition of Advanced Medical Optics 23 February 2009
Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter 21 January 2009
Abbott Introduces RealTime Molecular Assay in Europe for Detection of HPV Infection 14 January 2009
First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 16 December 2008
Abbott Reports Strong Sales and Earnings Growth in Third Quarter 16 October 2008
Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania 30 August 2008
Abbott Reports Stronger-than-Expected Sales and Earnings Growth in Second Quarter 17 July 2008
Abbott and Partnership for a Drug-Free America Launch 'Not In My House' 25 June 2008
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR 02 June 2008
Abbott, Takeda Conclude TAP Joint Venture 02 May 2008
Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter 17 April 2008
International Federation of Clinical Chemistry Forms Partnership With the Labs Are Vital(TM) 04 April 2008
First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 14 March 2008
Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin) 16 February 2008
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next
  • End
Tahmeena

Business & Industry

  • Roche announces the European Commission approval of Xofluza for the treatment and prevention of influenza in children aged one year and above
  • Pfizer expands 'An Accord for a Healthier World' product offering to include full portfolio for greater benefit to 1.2 billion people in 45 lower-income countries
  • Acquisition of Neogene Therapeutics completed
  • Bayer to accelerate drug discovery with Google Cloud's high-performance compute power
  • NextPoint Therapeutics announces $80 million Series B financing co-led by Leaps by Bayer and Sanofi Ventures to advance novel immuno-oncology programs

Research & Development

  • Discovery of anti-cancer chemistry makes skullcap fit for modern medicine
  • Coordination of COVID-19 vaccine clinical trials produces a 'treasure trove' of data and a model for the future
  • Power of cancer drugs may see boost by targeting newly ID'd pathway
  • A soybean protein blocks LDL cholesterol production, reducing risks of metabolic diseases
  • 500,000 missed out on blood pressure lowering drugs during pandemic
  • Modified CRISPR-based enzymes improve the prospect of inserting entire genes into the genome to overcome diverse disease-causing mutations
  • Study identifies potential new approach for treating lupus

Conferences & Events

  • SAE Media Group proudly presents the 4th Annual AI in Drug Discovery Conference
  • SAE Media Group's 6th annual 3D Cell Culture Conference
  • CPHI Frankfurt returns to pre-pandemic strength as pharma industry booms again
  • 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
  • CPHI Excellence in Pharma Award Winners 2022
  • CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
  • CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index

Regulatory Affairs

  • FDA grants Accelerated Approval for Alzheimer's disease treatment
  • FDA approves new HIV drug for adults with limited treatment options
  • FDA approves first gene therapy for the treatment of high-risk, non-muscle-invasive bladder cancer
  • FDA approves first gene therapy to treat adults with Hemophilia B
  • FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
  1. You are here:  
  2. Home
  3. Abbott
  4. Abbott and Omada Health partner to offer integrated digital health and coaching experience for people with Type 2 diabetes

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2023. All Rights Reserved.